Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol
Top Cited Papers
Open Access
Abstract
Introduction Newborn bloodspot screening (NBS) is a highly successful public health programme that uses biochemical and other assays to screen for severe but treatable childhood-onset conditions. Introducing genomic sequencing into NBS programmes increases the range of detectable conditions but raises practical and ethical issues. Evidence from prospectively ascertained cohorts is required to guide policy and future implementation. This study aims to develop, implement and evaluate a genomic NBS (gNBS) pilot programme. Methods and analysis The BabyScreen+ study will pilot gNBS in three phases. In the preimplementation phase, study materials, including education resources, decision support and data collection tools, will be designed. Focus groups and key informant interviews will also be undertaken to inform delivery of the study and future gNBS programmes. During the implementation phase, we will prospectively recruit birth parents in Victoria, Australia, to screen 1000 newborns for over 600 severe, treatable, childhood-onset conditions. Clinically accredited whole genome sequencing will be performed following standard NBS using the same sample. High chance results will be returned by genetic healthcare professionals, with follow-on genetic and other confirmatory testing and referral to specialist services as required. The postimplementation phase will evaluate the feasibility of gNBS as the primary aim, and assess ethical, implementation, psychosocial and health economic factors to inform future service delivery. Ethics and dissemination This project received ethics approval from the Royal Children’s Hospital Melbourne Research Ethics Committee: HREC/91500/RCHM-2023, HREC/90929/RCHM-2022 and HREC/91392/RCHM-2022. Findings will be disseminated to policy-makers, and through peer-reviewed journals and conferences.Keywords
This publication has 37 references indexed in Scilit:
- Gene selection for genomic newborn screening: Moving toward consensus?Genetics in Medicine, 2024
- Genomic newborn screening: Are we entering a new era of screening?Journal of Inherited Metabolic Disease, 2023
- Australian healthcare professionals' perspectives on the ethical and practical issues associated with genomic newborn screeningJournal of Genetic Counseling, 2022
- A genome sequencing system for universal newborn screening, diagnosis, and precision medicine for severe genetic diseasesThe American Journal of Human Genetics, 2022
- Principles of Genomic Newborn Screening ProgramsJAMA Network Open, 2021
- An online compendium of treatable genetic disordersAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2020
- Genomic Sequencing for Newborn Screening: Results of the NC NEXUS ProjectThe American Journal of Human Genetics, 2020
- Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome ScaleEuropean Journal of Medical Genetics, 2019
- Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq ProjectThe American Journal of Human Genetics, 2019
- Validation and testing of the Acceptability E-scale for Web-based patient-reported outcomes in cancer careApplied Nursing Research, 2011